Postmenopausal hormone therapy and the cardiovascular system.
Speroff
L
L
Department of Obstetrics and Gynecology, Oregon Health Sciences University, Portland.
Lobo
R A
RA
D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects*; D008076:Cholesterol, HDL / Q000187:drug effects / Q000378:metabolism; D008078:Cholesterol, LDL / Q000187:drug effects / Q000378:metabolism; D003327:Coronary Disease / Q000453:epidemiology* / Q000517:prevention & control*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004967:Estrogens / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D017698:Postmenopause; D011372:Progestins / Q000494:pharmacology / Q000627:therapeutic use; D012307:Risk Factors; D016387:Women's Health
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D004967:Estrogens; D011372:Progestins